Company / Free Cash Flow
SOLENO THERAPEUTICS INC Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$46.7M
FY2025
5-year range
-$69.3M / $46.7M
FY2021-FY2025
Trend
+167.4%
vs FY2024
Sector context
#52 of 192
Health Care
What the data says
At $47M, SOLENO THERAPEUTICS INC's free cash flow ranks #52 of 192 in the Health Care sector. Free Cash Flow returned to growth in FY2025 after 2 years of decline, reaching $47M.
Based on SEC 10-K filings.
$47M in FY2025.
Improved from -$25M to $47M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#52 of 192 in Health CareTop 27% of 192This company $46.7M Sector average $474.2M
▼
-90.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 167.4% year-over-year.
- Ranks #52 out of 192 companies in the Health Care sector.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $46.7M | +167.4% |
| FY2024 | -$69.3M | -177.9% |
| FY2023 | -$24.9M | -19.9% |
| FY2022 | -$20.8M | +25.2% |
| FY2021 | -$27.8M | -10.2% |
| FY2020 | -$25.2M | -45.0% |
| FY2019 | -$17.4M | -48.8% |
| FY2018 | -$11.7M | -17.5% |
| FY2017 | -$10.0M | +26.4% |
| FY2016 | -$13.5M | -30.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026